Literature DB >> 18456742

Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.

E Briasoulis1, N Pavlidis, E Felip.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18456742     DOI： 10.1093/annonc/mdn104

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Second-line chemotherapy in patients with primary unknown cancer.

Authors:  Makiko Ono; Masashi Ando; Kan Yonemori; Harukaze Yamamoto; Taizo Hirata; Chikako Shimizu; Kenji Tamura; Noriyuki Katsumata; Yasuhiro Fujiwara
Journal:  J Cancer Res Clin Oncol       Date:  2011-05-11       Impact factor: 4.553

2.  Cutaneous metastasis from gastrointestinal adenocarcinoma of unknown primary origin.

Authors:  Ana Lucia Ariano Junqueira; Ana Maria França Corbett; Jayme de Oliveira Filho; Kassila da Rosa Nasser; Natalie Nejem Haddad; Ana Carolina Franco Tebet
Journal:  An Bras Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.896

3.  Multiple disseminated keratoacanthoma-like nodules: a rare form of distant metastases to the skin.

Authors:  Alina Jankowska-Konsur; Karolina Kopeć-Pytlarz; Zdzisław Woźniak; Anita Hryncewicz-Gwóźdź; Joanna Maj
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

4.  Development and validation of a bedside score to predict early death in cancer of unknown primary patients.

Authors:  Nicolas Penel; Sylvie Negrier; Isabelle Ray-Coquard; Charles Ferte; Patrick Devos; Antoine Hollebecque; Michael B Sawyer; Antoine Adenis; Pascal Seve
Journal:  PLoS One       Date:  2009-08-03       Impact factor: 3.240

5.  Irinotecan plus carboplatin for patients with carcinoma of unknown primary site.

Authors:  K Yonemori; M Ando; M Yunokawa; T Hirata; T Kouno; C Shimizu; K Tamura; N Katsumata; A Hirakawa; K Matsumoto; Y Yamanaka; H Arioka; Y Fujiwara
Journal:  Br J Cancer       Date:  2008-12-16       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.